• Wed, August 8, 2018

Annabel Samimy Maintained (CARA) at Strong Buy with Increased Target to $26 on, Aug 8th, 2018

Annabel Samimy of Stifel, Maintained "Cara Therapeutics, Inc." (CARA) at Strong Buy with Increased Target from $22 to $26 on, Aug 8th, 2018.

Annabel has made no other calls on CARA in the last 4 months.



There are 2 other peers that have a rating on CARA. Out of the 2 peers that are also analyzing CARA, 0 agree with Annabel's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Annabel


  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $22 on, Friday, June 29th, 2018
  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $24 on, Wednesday, May 23rd, 2018